Does Mounjaro cause emotional issues — and what should you do about it?

You started Mounjaro and something feels different, not just in your body

A number of people on tirzepatide notice this. The weight comes off, appetite settles, and then, somewhere in the background, things feel a little off emotionally. Some describe a mild flatness, food was a source of comfort, and now that pull has gone. Others report irritability in the first few weeks, or a low mood that they can't quite place. A smaller group notice heightened anxiety, particularly in the early dose-adjustment period.

This is a question our prescribers hear most weeks, and the honest answer is: the picture is still developing. Tirzepatide is a relatively new medicine, still under additional MHRA monitoring (you'll see the black triangle symbol on the pack). Post-marketing data continues to be collected. What we can say with confidence is that these experiences are reported, they are being taken seriously by regulators, and they should be taken seriously by you too. The MHRA's Yellow Card scheme exists precisely so that patterns in real-world use can be identified, if you notice a mood change you suspect is linked to treatment, reporting it there adds to that picture.

You can also read about tirzepatide's recognised side effects on the NHS tirzepatide medicines page, which covers what to watch for and when to seek help.

Why tirzepatide might affect how you feel emotionally

GLP-1 and GIP receptors (the two pathways tirzepatide acts on) are found not only in the gut and pancreas but also in parts of the brain involved in reward, motivation, and emotional regulation. The appetite-suppression effect works partly through these brain pathways, which means the mechanism that quiets food cravings may, for some people, also dampen other reward signals. This is not a proven cause-and-effect for mood disorders, but it is a plausible biological reason why some people feel emotionally different on treatment. More detail on how tirzepatide works as a dual GIP and GLP-1 receptor agonist is covered on the tirzepatide overview.

Beyond the pharmacology, there is a psychological dimension that gets less attention. Rapid weight change can be emotionally disorientating even when it is wanted. How others treat you may shift. Your relationship with food, which carries enormous social and emotional weight for most people, changes significantly. Some people find this liberating; others find it unsettling. Neither response is wrong. What matters is noticing it and not assuming it will just pass without support if it does not.

If you are experiencing mood changes alongside other effects, the broader Mounjaro side effects overview covers the full range of what people report, including how Mounjaro can affect eye health, which some people on treatment are surprised to discover is worth monitoring.

What is known versus what is still uncertain, and who decides if you should continue

The Mounjaro SmPC (the formal prescribing document, available on the electronic Medicines Compendium) does not list depression or anxiety as common adverse reactions. Suicidal ideation appeared rarely in trial data and is listed as a side effect requiring urgent medical attention. The MHRA continues to review signals for mood and psychiatric effects across GLP-1 class medicines; the European Medicines Agency conducted a formal review in 2024 and found no confirmed causal link between semaglutide and suicidal thoughts, though monitoring continues. The UK regulator's position is watchful, not dismissive.

What this means for you practically: low mood, anxiety, or any thought of harming yourself while on Mounjaro is a reason to contact your prescriber or GP without delay. It does not mean the medicine caused it, but it does mean your clinical team needs to know. Dose timing, titration pace, or a temporary pause may be relevant factors, and those are decisions for a prescriber, not something to manage alone. The emotional side effects of Mounjaro page goes deeper on the mood and anxiety angle specifically. If sleep is part of the picture too, the sleep issues page may also be useful reading.

Practical steps if you are finding treatment emotionally difficult

First, tell someone in your clinical team. That might be the prescriber who reviews your treatment, your GP, or a mental health professional already involved in your care. Emotional difficulty during treatment is not a failure on your part, and it should not feel like a reason to hide what you are experiencing.

Second, be specific about timing. Did the feeling start when you began treatment? After a dose increase? Noting when changes occurred helps your prescriber assess whether there is a likely connection. A titration at a slower pace is sometimes appropriate if the early weeks feel particularly hard. You may also find it useful to read about how Jelly Roll has spoken about his experience on Mounjaro, as some people find it helpful to hear how others have navigated the emotional and physical changes that come with treatment.

Third, know that some experiences are worth thinking through with a counsellor or therapist regardless of whether tirzepatide caused them. Changing your body in a significant way, adjusting your relationship with food, navigating how people respond to you differently, these are big life shifts. They deserve proper support, not just a wait-and-see. Obesity UK's resources at obesityuk.org.uk include peer support and advice on the psychological side of weight treatment.

If you are considering starting treatment and want to talk through your mental health history as part of a clinical assessment, our free consultation is reviewed by a GPhC-registered Independent Prescriber the same day. The clinical team takes a whole-person approach to every case.